Search Results for: 340B

Health Center Advocacy, Health Center Federal Policy, Health Center News, Health Center Regulatory Issues, Uncategorized

340B Spotlight: How 340B Savings Supports Innovation at Carolina Health Center

Without 340B savings, the health center’s many services that expand access to care — like free prescription deliveries — would be in jeopardy of being rolled back or discontinued.

Health Care News, Health Center Advocacy, Health Center Federal Policy, Health Center Regulatory Issues, Uncategorized

Defending the 340B Program from Every Direction

The 340B Drug Pricing Program has weathered attacks from different health care actors for years. Just months after the outbreak of the COVID-19 pandemic, manufacturers launched attacks by refusing to sell 340B-priced drugs to health centers that use contract pharmacies to increase patient access. This combination of manufacturer restrictions, alongside existing discriminatory contracting actions taken …

Health Care News, Health Center News, Uncategorized

Why Protecting 340B Matters

The 340B Drug Pricing Program makes it possible for Community Health Center patients to afford life-saving medications and is an an essential source of support for health centers to stretch increasingly scarce federal resources and reinvest in patient care. Over the course of the past few years, while health centers have been fighting COVID-19, the program …

Uncategorized

Speaking Out in Defense of the 340B Drug Discount Program

Community Health Centers are on the frontlines of the pandemic providing comprehensive care and helping prevent emergency rooms from becoming overwhelmed. Yet, recent actions by some drug companies threaten a federal drug discount program called 340B that is critical to health centers. Health centers, primary care associations, and pharmacists joined a recent Twitter chat co-hosted …

Health Center Federal Policy, Health Center Regulatory Issues

House Subcommittee Focuses on the 340B Program

While other health care related issues have certainly taken up much of the space on Congress’ agenda over the past year, the 340B program can be added to the list of issues at which Congress has taken a closer look at over the past several months.  A case in point is the House Energy and Commerce …

Health Center Federal Policy

Congress Increasing Scrutiny, Oversight of 340B

The 340B Drug Discount Program might sound like an obscure health policy issue to most people, but those in the Health Center movement know that it is an essential source of support, allowing Health Centers to stretch increasingly scare federal resources and reinvest in patient care. Over the years, 340B has received increased scrutiny from …

Health Center Regulatory Issues

HRSA Webinar on Annual Recertification for 340B Covered Entities

We wanted to let you know about an upcoming webinar with HRSA’s Office of Pharmacy Affairs on the annual 340B Recertification Process.  Please see the details of the webinar below.   Should you have any questions about the webinar or the recertification process, you can contact the Prime Vendor Program at 1-888-340-2787 or ApexusAnswers@340bpvp.com. The Health …

Health Center Regulatory Issues

HRSA Announces Inclusion of 340B Compliance Questions in Operational Site Visit

In its Primary Health Care Digest dated October 22, 2014, BPHC announced that Operational Site Visits (OSV) conducted on or after October 1, 2014 for health centers that participate in the 340B Discount Drug Pricing Program will include a “brief assessment of compliance with 340B requirements.”  According to HRSA, the OSV review team will assess …